NCT06946342 (WATERinMOTION) is a NA clinical trial of "Aquatic Exercise Group" in Low Back Pain, sponsored by University of Sistan and Baluchestan.

Who is sponsoring NCT06946342?

NCT06946342 is sponsored by University of Sistan and Baluchestan.

What drugs are being tested in NCT06946342?

Interventions in NCT06946342: "Aquatic Exercise Group", Land-Based Rehabilitation Group".

What condition does NCT06946342 study?

NCT06946342 studies Low Back Pain, Obesity, Sedentary Behavior.

Is NCT06946342 still recruiting?

NCT06946342 is currently active, enrolled. Last updated 27 April 2025.

Last reviewed 2025-04-27 · How we verify

NCT06946342: WATERinMOTION

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

WATERinMOTION Aquatic Exercise Program Compared to Land-Based Rehabilitation on Low-Back Pain Relief and Quality of Life

Active, enrolled NA Last updated 27 April 2025

What this trial tests

NA trial testing "Aquatic Exercise Group" in Low Back Pain in 90 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

25 January 2025

Primary endpoint
1 May 2025

30 May 2025

Quick facts

Lead sponsor	University of Sistan and Baluchestan
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	90
Start date	25 January 2025
Primary completion	1 May 2025
Estimated completion	30 May 2025
Sites	1 location across Iran

Drugs / interventions tested

"Aquatic Exercise Group"
Land-Based Rehabilitation Group"

Conditions studied

Low Back Pain — all drugs for Low Back Pain →
Obesity — all drugs for Obesity →
Sedentary Behavior — all drugs for Sedentary Behavior →

Sponsor

University of Sistan and Baluchestan

Who can join

Adults 45 to 65, female only, with Low Back Pain or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial compares the efficacy of an 8-week WATERinMOTION aquatic exercise program versus land-based rehabilitation for reducing low-back pain (LBP) and improving quality of life in sedentary, overweight/obese middle-aged women (n=45). Outcomes include pain intensity (VAS), functional disability (ODI), and health-related quality of life (SF-36).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

NCT07526012 — Comparative Effects Of Post Isometric Relaxation Versus Active Isolated Stretch In Patients With Piriformis Syndrome · NA · recruiting
NCT07535047 — Placebo-Induced Hypoalgesia During Transcutaneous Electrical Nerve Stimulation Application in Low Back Pain · NA · recruiting
NCT07463729 — Evaluation of Stabilization Training With Biofeedback in Lumbosacral Spine Pain Syndrome · NA · recruiting
NCT07250568 — Office Program Effects on Pain, Posture, Muscle Physiology, Stress, Ergonomics, and Quality of Life in LBP Workers · NA · recruiting
NCT07467070 — Effectiveness of Pilates on Postural Correction, Core Strength and Flexibility in Younger Individuals With Non-specific · NA · recruiting

Other University of Sistan and Baluchestan trials

Trials by the same sponsor.

NCT06977919 — NASM OPT for Pectoral Enhancement and Breast Firmness in Non-Athletic Women: An RCT · NA · enrolling by invitation
NCT06977958 — NASM OPT for Gluteal Enhancement in Non-Athletic Women: An RCT · NA · enrolling by invitation
NCT06946329 — WATERinMOTION Aquatic Therapy in Obese Men With Knee Osteoarthritis · NA · enrolling by invitation
NCT07438197 — TENS Versus Foam Rolling for Muscle Recovery After Eccentric Exercise in Elite Female Volleyball Players · NA · completed
NCT05231564 — Hybrid Training and Middle Age · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06946342 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Sistan and Baluchestan
Last refreshed: 27 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06946342.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing